2022
DOI: 10.3390/cancers14102418
|View full text |Cite
|
Sign up to set email alerts
|

Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation

Abstract: The road of acceptance of oncologic thermotherapy/hyperthermia as a synergistic modality in combination with standard oncologic therapies is still bumpy [...]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…As a consequence of the Dewhirst et al review, the requirement on the applied thermal dose during clinical hyperthermia has become more realistic and modest in the homogeneity and peak of the temperature, whereas the duration of the clinical treatment has remained between 60 and 90 min depending on whether the heating is superficial or deep. Still, the definitions of the optimal thermal dose, as well as the optimal duration between the two modalities, radiotherapy or chemotherapy, and hyperthermia, are not settled and are the subject of ongoing discussions [8][9][10].…”
Section: Introductionmentioning
confidence: 99%
“…As a consequence of the Dewhirst et al review, the requirement on the applied thermal dose during clinical hyperthermia has become more realistic and modest in the homogeneity and peak of the temperature, whereas the duration of the clinical treatment has remained between 60 and 90 min depending on whether the heating is superficial or deep. Still, the definitions of the optimal thermal dose, as well as the optimal duration between the two modalities, radiotherapy or chemotherapy, and hyperthermia, are not settled and are the subject of ongoing discussions [8][9][10].…”
Section: Introductionmentioning
confidence: 99%